Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Hatem A. Abuelizz"'
Autor:
Mohamed El fadili, Mohammed Er-rajy, Somdutt Mujwar, Abduljelil Ajala, Rachid Bouzammit, Mohammed Kara, Hatem A. Abuelizz, Sara Er-rahmani, Menana Elhallaoui
Publikováno v:
BMC Chemistry, Vol 18, Iss 1, Pp 1-22 (2024)
Abstract Based on a structural family of thirty-two NR2B-selective N-Methyl-D-Aspartate receptor (NMDAR) antagonists, two phenylpiperazine derivatives labeled C37 and C39 were conceived thanks to molecular modeling techniques, as novel NMDAR inhibito
Externí odkaz:
https://doaj.org/article/68b2ece01da4488b885bf6c3bc083b71
Autor:
Etify A. Bakhite, Shaaban Kamel Mohamed, Chin-Hung Lai, Karthikeyan Subramani, Islam S. Marae, Suzan Abuelhassan, Abdelhamid A. E. Soliman, Mohamed S. K. Youssef, Hatem A. Abuelizz, Joel T. Mague, Rashad Al-Salahi, Youness El Bakri
Publikováno v:
ACS Omega, Vol 9, Iss 28, Pp 30751-30770 (2024)
Externí odkaz:
https://doaj.org/article/8859fe4c1e6e451f94d8a259d8c2a391
Autor:
Ghizlane Nouioura, Mohamed El fadili, Naoufal El Hachlafi, Souad Maache, Ibrahim Mssillou, Hatem A. Abuelizz, Fatima Zahra Lafdil, Sara Er-rahmani, Badiaa Lyoussi, Elhoussine Derwich
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
Introduction:Coriandrum sativum L. essential oil (CS-EO) is being evaluated in vitro for its antioxidant and antimicrobial properties, and its volatile compounds are to be identified as part of this exploratory study.Methods: The processes underlying
Externí odkaz:
https://doaj.org/article/42cd71693f5b4c508e83a08514a23a7e
Publikováno v:
Separations, Vol 10, Iss 6, p 353 (2023)
Dubermatinib (DMB, TP-0903), a benzenesulfonamide, is an inhibitor of the tyrosine kinase AXL, which is a member of the TAM family and can prevent GAS6-mediated activation of AXL in cancer cells. Patients with previously treated chronic lymphocytic l
Externí odkaz:
https://doaj.org/article/c93d31b63fb7461d8e1fe1c432825a59
Autor:
Hatem A. Abuelizz, Hanan A. A. Taie, Ahmed H. Bakheit, Gamal A. E. Mostafa, Mohamed Marzouk, Harunor Rashid, Rashad Al-Salahi
Publikováno v:
ACS Omega, Vol 6, Iss 47, Pp 31993-32004 (2021)
Externí odkaz:
https://doaj.org/article/06009aa7dc514ee39ea6677aaa673635
Autor:
Hatem A. Abuelizz, Nor Azman N. I. Iwana, Rohaya Ahmad, El-Hassane Anouar, Mohamed Marzouk, Rashad Al-Salahi
Publikováno v:
BMC Chemistry, Vol 13, Iss 1, Pp 1-14 (2019)
Abstract Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial gluco
Externí odkaz:
https://doaj.org/article/637eca829d9b45768e8a6d4a7065afc0
Autor:
Hatem A. Abuelizz, Hanan A. A. Taie, Ahmed H. Bakheit, Mohamed Marzouk, Mohamed M. Abdellatif, Rashad Al-Salahi
Publikováno v:
Applied Sciences, Vol 11, Iss 24, p 11642 (2021)
Fourteen triazole benzoic acid hybrids were previously characterized. This work aimed to screen their in vitro antioxidant activity using different assays, i.e., DPPH (1,1-diphenyl-1-picrylhydrazyl), reducing the power capability, FRAP (ferric reduci
Externí odkaz:
https://doaj.org/article/3dc60f6ff4c54d9ab73c5046cf86938d
Autor:
Hatem A. Abuelizz, Rashad Al-Salahi, Jamil Al-Asri, Jérémie Mortier, Mohamed Marzouk, Essam Ezzeldin, Azza A. Ali, Mona G. Khalil, Gerhard Wolber, Hazem A. Ghabbour, Abdulrahman A. Almehizia, Gehad A. Abdel Jaleel
Publikováno v:
Chemistry Central Journal, Vol 11, Iss 1, Pp 1-14 (2017)
Abstract The main objective of this work was to synthesize novel compounds with a benzo[de][1,2,4]triazolo[5,1-a]isoquinoline scaffold by employing (dioxo-benzo[de]isoquinolin-2-yl) thiourea as a building block. Molecular docking was conducted in the
Externí odkaz:
https://doaj.org/article/3835745e849043c09df95cd2888626f1
Autor:
Huda S. Al-Salem, Hatem A. Abuelizz, Iman S. Issa, Amany Z. Mahmoud, Ali AlHoshani, Md Arifuzzaman, A. F. M. Motiur Rahman
Publikováno v:
Applied Sciences, Vol 10, Iss 11, p 3669 (2020)
Developing anticancer therapeutics with no/few side effects is a challenge for medicinal chemists. The absence of antibacterial activity of an anticancer drug removes its detrimental effect toward intestinal flora and therefore leads to reduced side
Externí odkaz:
https://doaj.org/article/9d85c48e65c042d4bc06f9c1e67c07e6
Autor:
Hatem A. Abuelizz, Nasser S. Al-Shakliah, Rashad Al-Salahi, El Hassane Anouar, Mohamed Marzouk
Publikováno v:
Open Chemistry, Vol 18, Iss 1, Pp 740-751 (2020)
Previously, a series of pyridotriazolopyrimidines (1–6) were synthesized and fully described. The target compounds (1–6) were evaluated for their cytotoxicity against MCF-7, HepG2, WRL 68, and A549 (breast adenocarcinoma, hepatocellular carcinoma